About Nucare
Nucare Laboratories (India) Overview
Established in the year 1985, NuCare Laboratories (India) having Manufacturing plant situated at Mehsana in Gujarat, which manufacture Pharmaceuticals medicine & Animal Health care products in TABLET, CAPSULE, ORAL LIQUID & EXTERNAL PREPARATION. NuCare Laboratories (India) is offering specialty range of Animal Health products & pharmaceuticals medicines.
The core strength of the company lies in its ultramodern manufacturing facility with WHO-GMP & ISO certifications. We currently exploring the possibilities of exporting to countries such as Nepal, Saudi Arabia, UAE, Oman, Turkmenistan, Bhutan etc. We aim to not only expand our business scale and scope but also have a special interest in serving the needs of the end consumer that requires our products the most. We are looking forward to partner with potential customer who can be helpful to us for achieving the targeted growth this year and for the years to come.
We are more interested to have a long term relationship rather than keeping an eye on short term goals. We are pleased to offer you marketing rights of our pharmaceutical formulations and medicines for your regions of the globe.
Why Nucare Laboratories ?
Nucare Laboratories is devoted to reimagining healthcare, enhancing lives through innovative science and technology. We tackle intricate healthcare issues, unearthing transformative therapies and broadening their reach. We recognize and value the contributions of our investors, partners, and innovators, collectively shaping a healthier future.
Strategy
Innovating pharma solutions for global health, accessibility, and patient well-being in a dynamic landscape.
INNOVATION
Discover the array of treatments offered by Nucare Laboratories (India), Sandoz, and Advanced Accelerator Applications.
pipeline
Nucare's cutting-edge portfolio is dedicated to revolutionizing the quality of care for patients on a global scale.
Divisions
We are structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks.